EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access

A pragmatic randomized clinical trial of multilevel interventions to improve adherence to lung cancer screening (The Larch Study): Study protocol

Casey Luce, Lorella Palazzo, Melissa L Anderson, Lisa Carter-Bawa, Hongyuan Gao, Beverly B Green, James D Ralston, Kristine Rogers, Yu-Ru Su, Leah Tuzzio, Matthew Triplette, Karen J Wernli

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107495 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Casey Luce und 11 weiteren Autor:innen. Beteiligte Einrichtung: Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA. Electronic address: casey.luce@kp.org. Hauptthemen laut MEDLINE: Early Detection of Cancer, Lung Neoplasms, Patient Compliance, Patient Education as Topic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In real-world settings, low adherence to lung cancer screening (LCS) diminishes population-level benefits of reducing lung cancer mortality. We describe the Larch Study protocol, which tests the effectiveness of two patient-centered interventions (Patient Voices Video and Stepped Reminders) designed to address barriers and improve annual LCS adherence. METHODS: The Larch Study is a pragmatic randomized clinical trial conducted within Kaiser Permanente Washington. Eligible patients (target n = 1606) are aged 50-78 years with an index low-dose CT (LDCT) of the chest with negative or benign findings. With a 2 × 2 factorial-design, patients are individually randomized to 1 of 4 arms: video only, reminders only, both video and reminders, or usual care. The Patient Voices video addresses patient education needs by normalizing LCS, reminding patients when LCS is due, and encouraging social support. Stepped Reminders prompts primary care physicians to order patient's repeat screening LDCT and patients to schedule their scan. Intervention delivery is embedded within routine healthcare, facilitated by shared electronic health record components. Primary outcome is adherence to national LCS clinical guidelines, defined as repeat LDCT within 9-15 months. Patient-reported outcomes are measured via survey (knowledge of LCS, perception of stigma) approximately 8 weeks after index LDCT. Our mixed-methods formative evaluation includes process data, collected during the trial, and interviews with trial participants and stakeholders. DISCUSSION: Results will fill an important scientific gap on multilevel interventions to increase annual LCS adherence and provide opportunities for spread and scale to other healthcare settings. REGISTRATION: Trial is registered at clinicaltrials.gov (#NCT05747443).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerLung NeoplasmsPatient CompliancePatient Education as TopicReminder SystemsAgedFemaleHumansMaleMiddle AgedResearch DesignSocial SupportTomography, X-Ray ComputedRandomized Controlled Trials as TopicPragmatic Clinical Trials as Topic

Autor:innen und Institutionen

  • Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA. Electronic address: casey.luce@kp.org.
  • Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
  • Center for Discovery and Innovation at Hackensack Meridian Health, Nutley, NJ, USA.
  • Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA; Kaiser Permanente Bernard J Tyson School of Medicine, Department of Health Systems Science, Pasadena, CA, USA.
  • Fred Hutchinson Cancer Center, Seattle, WA, USA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Luce, C., Palazzo, L., Anderson, M. L., Carter-Bawa, L., Gao, H., Green, B. B., Ralston, J. D., Rogers, K., Su, Y. R., Tuzzio, L., Triplette, M., & Wernli, K. J. (2024). A pragmatic randomized clinical trial of multilevel interventions to improve adherence to lung cancer screening (The Larch Study): Study protocol. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107495

Vancouver

Luce C, Palazzo L, Anderson ML, Carter-Bawa L, Gao H, Green BB, et al. A pragmatic randomized clinical trial of multilevel interventions to improve adherence to lung cancer screening (The Larch Study): Study protocol. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107495

BibTeX
@article{Luce2024,
  author = {Luce, Casey and Palazzo, Lorella and Anderson, Melissa L and Carter-Bawa, Lisa and Gao, Hongyuan and Green, Beverly B and Ralston, James D and Rogers, Kristine and Su, Yu-Ru and Tuzzio, Leah and Triplette, Matthew and Wernli, Karen J},
  title = {A pragmatic randomized clinical trial of multilevel interventions to improve adherence to lung cancer screening (The Larch Study): Study protocol},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107495}
}
Kostenlos starten →